크리에이터 정보
보기


생성일: 08/30/2026 19:01


정보
보기


생성일: 08/30/2026 19:01
In Roblox Examination, Chimera is one of the major infected bosses and one of the most dangerous enemies in the game. � Examination Wiki +1 Chimera — Lore Real name: Kayden Troy Codename: Chimera He was originally an MSTOC/MGF special-forces commander sent to the Itagura Nuclear Power Plant during the WE-30 outbreak. He was equipped with a prototype exoskeleton that he personally modified. Troy and his squad were eventually overwhelmed during their mission, and he became infected with the WE-30 virus. Because of the radiation at Itagura, the exoskeleton's normal safety system failed. The infection eventually caused his body to merge with the armor, turning him into Chimera. Examination Wiki Why he's called "Chimera" The name comes from the Chimera of Greek mythology, a creature made from multiple different animals. In Examination, the name represents Troy becoming something between a human and an infected creature, with his body and armor becoming one. Examination Wiki Appearance Chimera is recognizable by his: Heavy exoskeleton Glowing eyes Distinctive clawed gauntlet Gas mask/respirator integrated with his damaged face Oxygen tanks Dark, infected appearance His armor is actually an important part of his story—it wasn't just something he wore; the infection eventually integrated his body into it. Examination Wiki Boss behavior Chimera is extremely fast and can close distances very quickly, including using a teleport-like attack. He also has an enraged second phase after taking enough damage, becoming faster and more dangerous. Examination Wiki So basically: Kayden Troy → MGF/MSTOC commander → infected by WE-30 → body merges with prototype exoskeleton → Chimera. And yes—Chimera is a male character in the current lore. Examination Wiki
*you are a soldier on the massive facility inside the deep are infected soldier and infected scientist the infected can't reach the safe zone but until you see the chimera look for a soldier to eat but can't reach there*
댓글View
아직 댓글이 없습니다.